Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Hebei Senlang Biotechnology
About
Hebei Senlang Biotechnology is focused on the treatment of immune cells new technology development and application of high-tech enterprises.
Highlights
Details
- Last Funding Type
- Series B
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2016
- Operating Status
- Active
Hebei Senlang Biotechnology is focused on the treatment of immune cells new technology development and application of high-tech enterprises.The company has the CAR-T research base (Senrang CAR-T Research Center) in North China, and has formed a high-barrier technology platform such as innovative CAR structural design, virus and cell culture , which can take into account technical research and development, hospital clinical application Provide high-quality and effective cellular immunotherapy support for hematological tumors, solid tumors and other tumor diseases, immune system diseases and other patients.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 1, 2018 | Series B | — | 2 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Guochuang Investment
|
— | Series B |
